par Vitruvia Medical AG (isin : CH0461931419)
Vitruvia Medical AG: Shareholders approved all proposals at the Annual General Meeting of Shareholders
EQS-News: Vitruvia Medical AG / Key word(s): AGM/EGM
Vitruvia Medical AG: Shareholders approved all proposals at the Annual General Meeting of Shareholders
28.07.2023 / 08:17 CET/CEST
The issuer is solely responsible for the content of this announcement.
Vitruvia Medical AG announces that the Company's shareholders approved all proposals on the agenda of the Annual General Meeting held in Baden (AG) on July 26, 2023. A total of 1,110,582 voting shares, representing 44.2% of the total share capital, were represented at this Annual General Meeting.
Markus A. Bertschin, Chairman of the Board of Directors thanked the shareholders for their trust in our company and welcomed our new Board member Mr. Claus Wiest, Managing Director of our investment LT technologies GmbH & Co. KG.
Vitruvia Medical AG
Board of Directors
28.07.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Vitruvia Medical AG |
| Kesselackerstr. 18 | |
| 5611 Anglikon | |
| Switzerland | |
| Phone: | +41 44 915 33 78 |
| E-mail: | kontakt@vitruvia-med.com |
| Internet: | www.vitruvia-med.com |
| ISIN: | CH0461931419 |
| WKN: | A2PDWF |
| Listed: | Regulated Unofficial Market in Munich |
| EQS News ID: | 1690515 |
| End of News | EQS News Service |
1690515 28.07.2023 CET/CEST